Skip to content

Effects of Recurrent PE on Women and Offspring

The Effects of Recurrent PE on Women and Offspring's Health

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05134285
Acronym
RPOH
Enrollment
1000
Registered
2021-11-24
Start date
2022-01-31
Completion date
2024-11-30
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Preeclampsia, Recurrence

Brief summary

The purpose of this study is to evaluate the risk factors of recurrent preeclampsia and compare the short-term and long-term adverse outcomes of women and their offspring.

Detailed description

The investigators collected women delivered twice in a row in our hospital. The investigators divided these pregnant women into three groups. Women in the first group did not complicate preeclampsia at both deliveries; Women in the second group complicated preeclampsia at the first delivery or at the second delivery; women in the third group complicated preeclampsia at two deliveries. The investigators explore the risk factors of recurrent preeclampsia and measure blood pressure, blood lipids, thyroid function, glycosylated hemoglobin, ALT, AST, et al. in one year, three years, and five years after the second delivery.

Interventions

OTHERblood pressure,BMI, blood sample

Blood pressure will be monitored. BMI will be measured. Blood samples will be tested.

Sponsors

Dunjin Chen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* women with at least twice of delivery history

Exclusion criteria

* women with chronic hypertension

Design outcomes

Primary

MeasureTime frameDescription
level of AST and ALT in blood1year after the second deliverwomen
blood pressure and hypertension of offspring1 year oldblood pressure≥140/90 mmHg
level of glycosylated hemoglobin in blood1 year after the second deliverwomen
level of cholesterol, LDL, HDL, VLDL-C in blood1 year after the second deliverwomen
level of FT3,FT4, and hTSH in blood1year after the second deliverwomen
blood pressure and hypertension of women1year after the second deliverblood pressure ≥140/90 mmHg

Secondary

MeasureTime frameDescription
level of insulin in blood1year after the second deliverwomen
level of fructosamine in blood1year after the second deliverwomen
level of AI37℃、AI4℃、PRA、ALD、AngII in blood1 year after the second deliverwomen
BMI of offspring1 year oldweight(kg)/height(m)2

Countries

China

Contacts

Primary ContactDunjin Chen
gzdrchen@gzhmu.edu.cn18928916722

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026